Is SHED Legit? 2026 Review vs PlexusDx

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on GLP-1 therapies, weight management protocols, and the genetic variables that shape every metabolic decision. Browse all Peptides & GLP-1 education

If you’re typing “is SHED legit” into a search bar, you’re really asking two different questions: does this company actually exist, and am I about to get stuck in a subscription? The independent verification trail says SHED (formerly ShedRx, now tryshed.com) is a real U.S. telehealth platform with a registered LLC, two physical offices, named pharmacy partners in its terms of service, and 875+ Trustpilot reviews. The friction trail says SHED has a 2-month minimum commitment, a 72-hour pre-bill cancellation cutoff, and auto-renewal that has surprised more than a few buyers. This article walks the legitimacy checks you can verify yourself, the three specific complaints worth knowing about before you sign up, and where PlexusDx Weight Management Protocols — Semaglutide Injection, Tirzepatide Injection, and Microdose GLP-1 Protocol — sit relative to SHED for cash-pay buyers who want no membership fee, no minimum commitment, and a genetic baseline before titration.

What SHED is and how it works

SHED is a U.S. telehealth platform that connects patients with licensed providers and routes prescriptions to compounding and retail pharmacy partners. It is not itself a pharmacy. According to its published materials, it offers compounded semaglutide injections starting at $199/month, compounded tirzepatide injections starting at $299/month, liquid drop and lozenge formulations starting at $199–$229/month, and brand-name FDA-approved options such as Foundayo through a separate membership-plus-medication path. The legal entity is registered as an LLC, the business operates out of Lehi, Utah and Gilbert, Arizona, and SHED states it serves all 50 U.S. states (not Puerto Rico). Consultation type — asynchronous intake versus scheduled live video — varies by state law.

SHED legitimacy checks you can verify yourself

The independent comparison source we reviewed ran a 10-point verification on SHED. Each signal points to a real, operating business: a Better Business Bureau profile (B letter grade, not BBB-accredited — accreditation is paid and optional, so the grade is the meaningful signal), two listed U.S. office addresses, named management on the BBB record (Mellie Rosenbalm as Compliance Manager, Scout Whiteley as Manager) plus a publicly identified founder/CEO on LinkedIn (Morley Baker), an active Trustpilot profile with 875+ reviews and a 4.6/5 average, an active ConsumerAffairs listing, and named compounding-pharmacy partners disclosed in the SHED terms of service: Strive Compounding Pharmacy, Promise Pharmacy, and Foothills Professional Pharmacy. The terms also reference USP <795>, <797>, and <800> compounding standards covering sterile preparation, contamination controls, and personnel training. SHED self-reports 150,000+ members and 800,000+ pounds lost — numbers that are stated by the company and not independently audited, but consistent with the third-party review volume. The strongest legitimacy indicator is operational, not regulatory: SHED responds to essentially all of its negative Trustpilot reviews, typically within two weeks. Companies that don’t actually exist do not maintain that pattern across nearly a thousand reviews.

The three real SHED complaints worth knowing about

The negative reviews are real, and they cluster around three specific issues rather than around missing medication or fraud. First, the 2-month minimum commitment. SHED requires two billing cycles before a patient is eligible to cancel. Buyers who expect “cancel anytime” subscription billing run into this rule on month one. Second, the 72-hour pre-bill cancellation cutoff. Cancellations must be submitted at least 72 hours before the next billing date, and payments are non-refundable once charged. The cutoff is published in the terms; the terms don’t get read. Third, a $99 vs $125 brand-membership-fee inconsistency appearing across different SHED pages — a transparency issue worth confirming at checkout before you enter a card. None of these are fraud signals. They are subscription-design choices that surprise buyers. If a no-commitment, no-membership cash-pay path matters to you, those three rules are the reason to keep reading.

Are SHED medications FDA-approved? Compounded vs branded

The compounded vs FDA-approved branded distinction is the single most important medication question on any GLP-1 telehealth platform. SHED runs both paths. Its compounded semaglutide and tirzepatide are pharmacy-prepared formulations of the same active ingredients found in Wegovy, Ozempic, Mounjaro, and Zepbound — they are not FDA-approved finished drug products. Compounded medications are governed by U.S. compounding regulations and prepared by licensed compounding pharmacies, but the finished products themselves do not carry FDA approval. SHED’s brand-name path dispenses FDA-approved finished drugs — Wegovy, Zepbound, and Foundayo — through a different fulfillment chain at retail pricing plus the SHED membership fee. The boxed warning for thyroid C-cell tumors applies to both semaglutide and tirzepatide based on rodent studies, regardless of whether the dispensed product is compounded or branded.

SHED pricing and the cash-pay math

For a cash-pay buyer, SHED’s compounded semaglutide injection at $199/month annualizes to roughly $2,388/year (assuming the 28-day billing cycle the terms describe and the standard membership/medication structure). Compounded tirzepatide at $299/month runs roughly $3,588/year on the same basis. Brand-name Foundayo at $149/month plus the $99 or $125 membership fee runs ~$2,988–$3,300/year before any insurance offset on the medication line. SHED states it does not actively manage prior authorization for brand-name medications — the dispensing pharmacy may bill insurance if your plan covers GLP-1s, but if prior-auth support is the dominant factor in your decision, SHED is not the platform optimized for that workflow. Insurance does not cover compounded medications regardless of the platform; that path is cash-pay everywhere.

How PlexusDx Weight Management Protocols compare

PlexusDx is also cash-pay, but the structural differences are worth itemizing before you decide. No membership fee, no minimum commitment. PlexusDx does not charge a separate membership line and does not enforce a 2-month minimum — you pay for the protocol month-to-month. Six prescription compounds across four mechanism classes, including formats SHED does and doesn’t carry: Microdose GLP-1 Protocol at $129/mo flat (capsule, troche, lozenge, sublingual delivery variants), Semaglutide Oral from $249/mo, Semaglutide Injection at $149/mo, Tirzepatide Injection at $249/mo, Tirzepatide Oral at $279/mo, and GLP-Squared dual-compound therapy at $249/mo. All-inclusive pricing. Each protocol month covers the async provider consultation (or scheduled live consult in the five states that require one), the prescription, the compounded medication, and shipping — one bill, no add-on membership. A genetic baseline option that no SHED tier matches. The Precision Peptide Genetic Test ($298 standalone or $99 as an add-on after your first month) maps 48 genes and 57 variants across 14 health pathways, including 34 weight-management insights and the GIPR rs1800437 variant linked to differential GLP-1 response. The clinical team reviews those results before titration when the test is included — a stratification step neither SHED nor most cash-pay competitors perform. PlexusDx’s entry-tier annualized cost on the Microdose GLP-1 Protocol is $1,548/year, below SHED’s lowest compounded tier; Semaglutide Injection at $2,148–$2,748/year sits at or below SHED’s compounded semaglutide line depending on dose level.

Pros, cons, and which buyer SHED actually fits

SHED’s real strengths are format variety (drops, lozenges, pills, injections), a large independent review footprint, and named compounding-pharmacy partners disclosed in writing. Its real friction points are the 2-month minimum, the 72-hour cancellation cutoff, the auto-renew structure, the membership-fee inconsistency on brand-name plans, and the absence of a built-in genetic baseline before titration. SHED is a defensible choice for cash-pay or HSA/FSA buyers who want format optionality and are comfortable with a 2-month commitment. SHED is the wrong fit for buyers who need true cancel-anytime billing, who rely on insurance prior-authorization support, who want a no-membership single-bill structure, or who want their dose decisions anchored to a genetic baseline before week one. PlexusDx Weight Management Protocols are the more direct match for that second group: month-to-month, no membership, no minimum, all-inclusive, with the optional Precision Peptide Genetic Test to inform titration before the first injection.

Frequently asked questions

Is SHED legit or a scam?

SHED is a legitimate U.S. telehealth company with a registered LLC, two physical offices, a publicly identified founder, named pharmacy partners in its terms, and 875+ independent reviews. The negative reviews are real but cluster around billing friction and cancellation rules, not missing medication or fraud.

Is SHED the same as ShedRx?

Yes. ShedRx rebranded to SHED at tryshed.com. Older review sites and directories still use the ShedRx name, but the legal entity and operations are the same.

Are SHED medications FDA-approved?

The FDA approves medications, not telehealth platforms. SHED’s brand-name path dispenses FDA-approved finished drugs (Wegovy, Zepbound, Foundayo). SHED’s compounded semaglutide and tirzepatide are not FDA-approved finished products — they are pharmacy-prepared formulations of the same active ingredients. PlexusDx Weight Management Protocols also use compounded semaglutide and tirzepatide, so the same compounded-vs-branded distinction applies.

Can I cancel SHED after one month?

No. SHED requires a 2-month minimum commitment and cancellations must be submitted at least 72 hours before the next billing date; payments are non-refundable once charged. PlexusDx does not require a minimum commitment — you pay month-to-month on any of its Weight Management Protocols.

Does SHED accept insurance?

SHED’s membership and compounded medications are cash-pay. The dispensing pharmacy may bill insurance for brand-name FDA-approved medications, but SHED does not actively manage prior authorization. PlexusDx is also cash-pay across all six protocols and does not bill insurance.

How does PlexusDx pricing compare to SHED?

The PlexusDx Microdose GLP-1 Protocol is $129/mo flat ($1,548/year), below SHED’s lowest compounded tier. Semaglutide Injection is $149/mo and Tirzepatide Injection is $249/mo. PlexusDx pricing is all-inclusive with no separate membership fee.

Does PlexusDx run a genetic baseline before titration?

Yes, when the test is included. The Precision Peptide Genetic Test is $298 standalone or $99 as an add-on after your first month and maps 48 genes and 57 variants across 14 health pathways, including the GIPR rs1800437 variant linked to differential GLP-1 response.

Is SHED Legit? 2026 Verification Review and PlexusDx Comparison | PlexusDx